Structures by: Actins A.
Total: 8
Xylazine hydrochloride A form
C12H17SN21Cl1
Acta Crystallographica Section B (2014) 70, 2 342-346
a=11.5870(3)Å b=8.7174(2)Å c=14.8813(4)Å
α=90.00000° β=115.1475(13)° γ=90.00000°
Xylazine hydrochloride Z form
C12H17N2S1Cl1
Acta Crystallographica Section B (2014) 70, 2 342-346
a=12.4500(5)Å b=11.6223(5)Å c=9.3622(4)Å
α=90.00000° β=97.410(3)° γ=90.00000°
Xylazine hydrochloride X form
C12H17SN21Cl1
Acta Crystallographica Section B (2014) 70, 2 342-346
a=12.1155(13)Å b=8.3857(7)Å c=13.5322(15)Å
α=90.00000° β=94.921(6)° γ=90.00000°
Sygethin dihydrate
2(K),C18H20O6S22,2(H2O)
Acta Crystallographica Section E (2008) 64, 8 m1027
a=5.8741(5)Å b=6.5684(5)Å c=15.2335(14)Å
α=84.272(4)° β=83.768(5)° γ=76.522(6)°
Afobazole
C15H23N3O2S2,2(Cl)
Acta Crystallographica Section C (2013) 69, 3 299-302
a=9.7910(11)Å b=18.2689(19)Å c=10.5687(12)Å
α=90.00° β=103.225(17)° γ=90.00°
Pimobendan B form
C19H18N4O2
Acta Crystallographica Section E (2013) 69, 11 o1677
a=18.891(5)Å b=9.9619(5)Å c=9.5029(8)Å
α=90.00000° β=90.799(13)° γ=90.00000°
Tianeptine hydrochloride
C21H26ClN2O4S,Cl
Acta Crystallographica Section E (2012) 68, 11 o3136
a=9.5439(2)Å b=10.0910(2)Å c=13.1802(3)Å
α=104.4000(12)° β=101.5380(10)° γ=105.0180(11)°
Afobazole
C15H23N3O2S2,2(Cl)
Acta Crystallographica Section C (2013) 69, 3 299-302
a=14.4952(15)Å b=16.5419(19)Å c=7.9715(8)Å
α=90.00° β=90.858(15)° γ=90.00°